Johnson & Johnson
JNJ
$159.97
-$0.535-0.33%
| Weiss Ratings | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B- | |||
| Rating Factors | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.24 | |||
| Price History | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.41% | |||
| 30-Day Total Return | -0.74% | |||
| 60-Day Total Return | 7.65% | |||
| 90-Day Total Return | 11.62% | |||
| Year to Date Total Return | 2.33% | |||
| 1-Year Total Return | 6.10% | |||
| 2-Year Total Return | 2.50% | |||
| 3-Year Total Return | 9.43% | |||
| 5-Year Total Return | 37.33% | |||
| 52-Week High % Change | -4.95% | |||
| 52-Week Low % Change | 12.14% | |||
| Price | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $168.85 | |||
| 52-Week Low Price | $143.13 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Sep 04, 2024 | |||
| Valuation | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 386.36B | |||
| Enterprise Value | 402.38B | |||
| Price/Earnings (TTM) | 10.74 | |||
| Earnings Per Share (TTM) | 14.94 | |||
| Earnings Per Share Growth | 203.01% | |||
| Price/Earnings To Growth | 0.05 | |||
| Price/Sales (TTM) | 4.49 | |||
| Price/Book (Q) | 5.40 | |||
| Enterprise Value/Revenue (TTM) | 4.65 | |||
| Price | $159.95 | |||
| Enterprise Value/EBITDA (TTM) | 12.96 | |||
| Enterprise Value/EBIT | 16.66 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.42B | |||
| Dividend Yield | 3.03% | |||
| Div. Per Share (Most Recent) | $1.24 | |||
| Dividend Per Share (TTM) | $4.86 | |||
| Payout Ratio (TTM) | 22.93% | |||
| Dividend Per Share (Most Recent) | $1.24 | |||
| Company Info | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 732 524 0400 | |||
| Address | One Johnson & Johnson Plaza New Brunswick, NJ 08933 | |||
| Website | www.jnj.com | |||
| Country | United States | |||
| Year Founded | 1886 | |||
| Profitability | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 27.90% | |||
| Profit Margin | 43.91% | |||
| Management Effectiveness | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.10% | |||
| Return on Equity | 22.15% | |||
| Income Statement | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 86.58B | |||
| Total Revenue (TTM) | 86.58B | |||
| Revenue Per Share | $35.75 | |||
| Gross Profit (TTM) | 60.11B | |||
| EBITDA (TTM) | 31.04B | |||
| EBIT (TTM) | 24.16B | |||
| Net Income (TTM) | 38.02B | |||
| Net Income Avl. to Common (TTM) | 38.02B | |||
| Total Revenue Growth (Q YOY) | 4.31% | |||
| Earnings Growth (Q YOY) | -12.83% | |||
| EPS Diluted (TTM) | 14.94 | |||
| EPS Diluted Growth (Q YOY) | -1.61% | |||
| Balance Sheet | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 25.48B | |||
| Cash Per Share (Q) | $10.52 | |||
| Total Current Assets (Q) | 57.82B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 71.54B | |||
| Current Ratio (Q) | 1.072 | |||
| Book Value Per Share (Q) | $29.72 | |||
| Total Assets (Q) | 181.09B | |||
| Total Current Liabilities (Q) | 53.93B | |||
| Total Debt (Q) | 41.49B | |||
| Total Liabilities (Q) | 109.55B | |||
| Total Common Equity (Q) | 71.54B | |||
| Cash Flow | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -15.35B | |||
| Cash from Financing (TTM) | 3.44B | |||
| Net Change in Cash (TTM) | 5.15B | |||
| Levered Free Cash Flow (TTM) | 13.85B | |||
| Cash from Operations (TTM) | 17.15B | |||
